Question 1

What is TG Therapeutics?

Accepted Answer

TG Therapeutics is a Company.

Question 2

How often does TG Therapeutics appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was TG Therapeutics first tracked by Ergen?

Accepted Answer

First tracked on Jan 13, 2026.

Question 4

When was TG Therapeutics last mentioned in news?

Accepted Answer

Last active on Mar 09, 2026.

Question 5

What is TG Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 75 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is TG Therapeutics in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving TG Therapeutics?

Accepted Answer

TG Therapeutics 2025 Earnings and BRIUMVI Data (Jan 13, 2026, 6 articles).

Question 8

How did the "TG Therapeutics 2025 Earnings and BRIUMVI Data" event impact TG Therapeutics?

Accepted Answer

TG Therapeutics announced strong financial results for Q4 and full year 2025, exceeding revenue targets for Ublituximab and providing positive 2026 guidance. The company also shared positive clinical data for Ublituximab and pipeline updates, reinforcing its market position.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.